4.5 Review

The cure from within? a review of the microbiome and diet in melanoma

Related references

Note: Only part of the references are listed.
Editorial Material Dermatology

Do the gut and skin microbiomes share thoughts on melanoma development?

N. O. S. Camara

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Medicine, General & Internal

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

Hussein A. Tawbi et al.

Summary: LAG-3 and PD-1 are two distinct inhibitory immune checkpoints that contribute to T-cell exhaustion. The combination of relatlimab and nivolumab has been shown to be safe and effective in previously treated melanoma patients, and this study aimed to evaluate its safety and activity in previously untreated melanoma patients. The results demonstrated that the combination therapy provided a greater benefit in terms of progression-free survival compared to nivolumab alone, without any new safety signals.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Biochemistry & Molecular Biology

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1

John A. McCulloch et al.

Summary: An integrated analysis of microbiome and host cell transcriptional data in patients with melanoma treated with anti-PD-1 therapy reveals new associations between streptococcus species and immune-related adverse effects. The study also identifies consistent microbiome associations with clinical outcomes. The results show that baseline microbiota composition is optimally associated with clinical outcome one year after treatment initiation. Meta-analysis and bioinformatic analyses reveal that bacteria associated with favorable response are within the Actinobacteria phylum and Lachnospiraceae/Ruminococcaceae families of Firmicutes. Gram-negative bacteria, on the other hand, are associated with an inflammatory host intestinal gene signature and unfavorable outcome. Two different microbial signatures, enriched for Lachnospiraceae spp. and Streptococcaceae spp., are associated with favorable and unfavorable clinical response, respectively, along with distinct immune-related adverse effects. Supervised learning algorithms consistently predict treatment outcomes in all cohorts, despite heterogeneity between cohorts. The study provides valuable insights into the complex interaction between gut microbiome and response to cancer immunotherapy, paving the way for future research.

NATURE MEDICINE (2022)

Review Biotechnology & Applied Microbiology

Role of gut microbiome on immunotherapy efficacy in melanoma

Stefano Bibbo et al.

Summary: The gut microbiota plays a crucial role in cancer pathophysiology and therapy response. Studies have shown that modulation of the microbiota can help predict and improve the response to immunotherapy, with promising results particularly in melanoma research.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Oncology

Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy

Jahan J. Mohiuddin et al.

Summary: For patients with stage III and IV melanoma who had prior exposure to antibiotics before receiving immune checkpoint inhibitors (ICI), they had significantly worse overall survival and a higher incidence of immune-mediated colitis compared to unexposed patients.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Letter Dermatology

Skin microbiome in acral melanom Corynebacterium is associated with advanced melanoma

Satoru Mizuhashi et al.

JOURNAL OF DERMATOLOGY (2021)

Article Oncology

Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy

Lindsey M. Kuehm et al.

Summary: Checkpoint blockade immunotherapy relies on empowering the immune system to fight cancer, with individual factors like diet and obesity potentially impacting patient outcomes. In a mouse model of diet-induced obesity, it was found that dietary fructose played a role in tumor immune evasion, with HO-1 expression identified as a mechanism of resistance and a target for combination cancer immunotherapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Review Biochemistry & Molecular Biology

The Microbiome and Its Implications in Cancer Immunotherapy

Hani Choudhry

Summary: Cancer is a major cause of death globally, with approximately 18 million deaths each year. Microbes have been found to play a significant role in cancer progression, influencing immunotherapy and potentially leading to the development of future diagnostic tools. Scientists are actively researching the role of microbes in cancer and their underlying mechanisms.

MOLECULES (2021)

Review Oncology

Radiotherapy and the gut microbiome: facts and fiction

Jing Liu et al.

Summary: The gut microbiome has a bidirectional relationship with radiotherapy, potentially influencing treatment efficacy by modulating the tumor microenvironment. Personalized approaches such as probiotics, prebiotics, or fecal microbial transplantation may optimize the gut microbiome response to treatment. Further research is needed to explore the mechanisms of radiation on the microbiome and the application of multi-omic methods in investigating functional changes.

RADIATION ONCOLOGY (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch et al.

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

Article Oncology

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases

Justin T. Moyers et al.

Summary: The study showed that patients with melanoma with brain metastasis who received immunotherapy and radiotherapy combination treatment had longer survival. Patients receiving concurrent immunotherapy and radiotherapy showed better survival compared to those receiving radiotherapy alone.

CANCER MEDICINE (2021)

Review Oncology

The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy

Anastasia Mpakali et al.

Summary: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but are only effective for a subset of patients and cancer types. Recent research emphasizes the importance of how cancer cells present molecules to the immune system in response to immunotherapy. Modulating intracellular antigen processing may enhance tumor immunogenicity and the effectiveness of ICI therapy.

CANCERS (2021)

Article Multidisciplinary Sciences

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer et al.

Summary: The study suggests that dietary fiber intake is associated with significantly improved progression-free survival in melanoma patients receiving ICB treatment, especially without the use of probiotics. Preclinical studies demonstrate that a low-fiber diet or probiotics can impair the treatment response to anti-PD-1 therapy, leading to a lower frequency of interferon-gamma-positive cytotoxic T cells in the tumor microenvironment.

SCIENCE (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients

Diwakar Davar et al.

Summary: The study demonstrated that fecal microbiota transplantation combined with anti-PD-1 therapy can overcome resistance to anti-PD-1 in a subset of PD-1 refractory melanoma patients, leading to clinical benefits. This approach induced changes in the gut microbiome and reprogrammed the tumor microenvironment, ultimately enhancing the efficacy of anti-PD-1 treatment.

SCIENCE (2021)

Review Nutrition & Dietetics

Nutritional Interventions for Patients with Melanoma: From Prevention to Therapy-An Update

Marianna Pellegrini et al.

Summary: Melanoma is an aggressive skin cancer with risk factors including genetics, environment, and lifestyle. New treatments have revolutionized melanoma therapy, but the potential link between obesity and melanoma etiology remains controversial.

NUTRIENTS (2021)

Review Oncology

Development of Immunotherapy Combination Strategies in Cancer

Timothy A. Yap et al.

Summary: Harnessing the immune system to treat cancer through inhibitors of CTLA4 and PD-L1 has revolutionized cancer treatment. Rational combination strategies require a deep understanding of immune system mechanisms and strong drug development strategies. Approved immunotherapy combinations, promising combinatorial approaches in clinical trials, and innovative preclinical model systems hold great potential to improve patient outcomes in cancer treatment.

CANCER DISCOVERY (2021)

Article Microbiology

High-Fiber, Whole-Food Dietary Intervention Alters the Human Gut Microbiome but Not Fecal Short-Chain Fatty Acids

Andrew Oliver et al.

Summary: The study conducted a 2-week dietary fiber intervention, which showed that increasing fiber intake can significantly alter the composition of individual gut microbiomes, including increasing the abundance of known fiber-degrading microbes.

MSYSTEMS (2021)

Article Oncology

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy

Stephen L. Shiao et al.

Summary: Studies have shown that intestinal fungi play a role in regulating antitumor immune responses following radiation in mouse models of breast cancer and melanoma. Fungi and bacteria have opposite influences on these responses, with depletion of fungi enhancing responsiveness to radiation while depletion of bacteria reducing responsiveness. Elevated intratumoral expression of Dectin-1, a primary innate sensor of fungi, is negatively associated with survival in breast cancer patients.

CANCER CELL (2021)

Article Oncology

The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients

Anne Zaremba et al.

Summary: The review evaluated the latest long-term data from clinical trials for melanoma patients, showing that retreatment, rechallenge, and escalation are viable options for patients who relapse in the adjuvant or advanced setting.

EUROPEAN JOURNAL OF CANCER (2021)

Article Food Science & Technology

Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice

Lili Chen et al.

Summary: This study demonstrates that probiotic supplementation can attenuate lung metastasis of melanoma cells by altering gut microbiota composition, promoting short-chain fatty acid production, and recruiting T cells to lungs via the CCL20/chemokine receptor 6 axis.

MOLECULAR NUTRITION & FOOD RESEARCH (2021)

Review Oncology

Gut Microbiota in Cancer Immune Response and Immunotherapy

Cheng-Bei Zhou et al.

Summary: This article summarizes the complex interplay among the gut microbiome, cancer immune response, and immunotherapy, pointing out that modulation of the host microbiota can provide new strategies for cancer treatment.

TRENDS IN CANCER (2021)

Article Oncology

Citrus Consumption and Risk of Cutaneous Malignant Melanoma in the Women's Health Initiative

Melissa M. Melough et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2020)

Review Immunology

Targeting the interleukin-17 immune axis for cancer immunotherapy

Gerardo A. Vitiello et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Food Science & Technology

Potential carcinogenic heterocyclic aromatic amines (HAAs) in foodstuffs: Formation, extraction, analytical methods, and mitigation strategies

Hao Dong et al.

COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2020)

Review Gastroenterology & Hepatology

Gut Microbiome Modulates Response to Cancer Immunotherapy

Md Abdul Wadud Khan et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Article Medicine, Research & Experimental

Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response

Mireia Uribe-Herranz et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Public, Environmental & Occupational Health

New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016

Juliana Berk-Krauss et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2020)

Article Cell Biology

Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth

Yan Li et al.

CELL REPORTS (2020)

Review Oncology

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment

Hiro Sato et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Nutrition & Dietetics

Intake of Furocoumarins and Risk of Skin Cancer in 2 Prospective US Cohort Studies

Weiyi Sun et al.

JOURNAL OF NUTRITION (2020)

Review Pharmacology & Pharmacy

PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake

Jian-ye Zhang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Commensal bacteria stimulate antitumor responses via T cell cross-reactivity

Catherine A. Bessell et al.

JCI INSIGHT (2020)

Article Multidisciplinary Sciences

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Lukas F. Mager et al.

SCIENCE (2020)

Article Medicine, Research & Experimental

Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma

Angelo Limeta et al.

JCI INSIGHT (2020)

Review Oncology

Dietary patterns and cancer risk

Susan E. Steck et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

Modulating the microbiome to improve therapeutic response in cancer

Jennifer L. McQuade et al.

LANCET ONCOLOGY (2019)

Article Multidisciplinary Sciences

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

Takeshi Tanoue et al.

NATURE (2019)

Article Multidisciplinary Sciences

A new genomic blueprint of the human gut microbiota

Alexandre Almeida et al.

NATURE (2019)

Article Oncology

Gut microbiome and cancer immunotherapy

Weina Li et al.

CANCER LETTERS (2019)

Article Medicine, General & Internal

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial

Samuel P. Costello et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Meeting Abstract Oncology

Leveraging gut microbiota networks to impact tumor immunotherapy

Lata Jayaraman et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Article Multidisciplinary Sciences

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

V. Gopalakrishnan et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Bertrand Routy et al.

SCIENCE (2018)

Review Oncology

An Epidemiological Review of Diet and Cutaneous Malignant Melanoma

Keming Yang et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)

Article Oncology

Prospective Study of Coffee Consumption and Cancer Incidence in Non-White Populations

Song-Yi Park et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)

Review Microbiology

The human skin microbiome

Allyson L. Byrd et al.

NATURE REVIEWS MICROBIOLOGY (2018)

Review Medicine, General & Internal

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Multidisciplinary Sciences

A commensal strain of Staphylococcus epidermidis protects against skin neoplasia

Teruaki Nakatsuji et al.

SCIENCE ADVANCES (2018)

Review Gastroenterology & Hepatology

Enterocolitis due to immune checkpoint inhibitors: a systematic review

Emilie Soularue et al.

Review Medicine, General & Internal

Melanoma

Dirk Schadendorf et al.

LANCET (2018)

Article Biochemistry & Molecular Biology

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Yinghong Wang et al.

NATURE MEDICINE (2018)

Review Oncology

Oncolytic virus immunotherapy: future prospects for oncology

Junaid Raja et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Article Gastroenterology & Hepatology

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities

Clelia Coutzac et al.

JOURNAL OF CROHNS & COLITIS (2017)

Review Dermatology

Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies

Yik Weng Yew et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2016)

Article Oncology

Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States

Andrew Rivera et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Article Gastroenterology & Hepatology

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

L. Marthey et al.

JOURNAL OF CROHNS & COLITIS (2016)

Review Multidisciplinary Sciences

The microbiome and innate immunity

Christoph A. Thaiss et al.

NATURE (2016)

Article Multidisciplinary Sciences

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

Krista Dubin et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Revised Estimates for the Number of Human and Bacteria Cells in the Body

Ron Sender et al.

PLOS BIOLOGY (2016)

Review Multidisciplinary Sciences

Systematic Review: Adverse Events of Fecal Microbiota Transplantation

Sinan Wang et al.

PLOS ONE (2016)

Article Dermatology

Skin microbiome in melanomas and melanocytic nevi

Alexander Salava et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2016)

Article Dermatology

Alcohol consumption and risk of melanoma among women: pooled analysis of eight case-control studies

Kyoko Miura et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2015)

Editorial Material Oncology

Immunotherapy Not Working? Check Your Microbiota

Nathan R. West et al.

CANCER CELL (2015)

Article Public, Environmental & Occupational Health

Caffeine Intake, Coffee Consumption, and Risk of Cutaneous Malignant Melanoma

Shaowei Wu et al.

EPIDEMIOLOGY (2015)

Article Biochemistry & Molecular Biology

The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights

Elizabeth A. Grice

GENOME RESEARCH (2015)

Article Oncology

Citrus Consumption and Risk of Cutaneous Malignant Melanoma

Shaowei Wu et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Oncology

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H. I. Andtbacka et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Nutrition & Dietetics

Diet Quality and Risk of Melanoma in an Italian Population

Carlotta Malagoli et al.

JOURNAL OF NUTRITION (2015)

Article Medicine, General & Internal

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Public, Environmental & Occupational Health

Systematic review of studies investigating the association between dietary habits and cutaneous malignant melanoma

C. de Waure et al.

PUBLIC HEALTH (2015)

Review Multidisciplinary Sciences

Neoantigens in cancer immunotherapy

Ton N. Schumacher et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vetizou et al.

SCIENCE (2015)

Review Biochemistry & Molecular Biology

Role of the Microbiota in Immunity and Inflammation

Yasmine Belkaid et al.

Article Medicine, General & Internal

Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection

Ilan Youngster et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Review Microbiology

The gut microbiota, bacterial metabolites and colorectal cancer

Petra Louis et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Review Infectious Diseases

Probiotics, gut microbiota and health

M. -J. Butel

MEDECINE ET MALADIES INFECTIEUSES (2014)

Review Multidisciplinary Sciences

Dialogue between skin microbiota and immunity

Yasmine Belkaid et al.

SCIENCE (2014)

Review Oncology

Oral Chemotherapy Food and Drug Interactions: A Comprehensive Review of the Literature

Eve M. Segal et al.

JOURNAL OF ONCOLOGY PRACTICE (2014)

Article Immunology

Compartmentalized and systemic control of tissue immunity by commensals

Yasmine Belkaid et al.

NATURE IMMUNOLOGY (2013)

Review Nutrition & Dietetics

Review of the association between meat consumption and risk of colorectal cancer

Eunjung Kim et al.

NUTRITION RESEARCH (2013)

Article Multidisciplinary Sciences

Human gut microbiome viewed across age and geography

Tanya Yatsunenko et al.

NATURE (2012)

Article Medicine, General & Internal

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Nutrition & Dietetics

Dietary biomarkers: advances, limitations and future directions

Valisa E. Hedrick et al.

NUTRITION JOURNAL (2012)

Article Multidisciplinary Sciences

Compartmentalized Control of Skin Immunity by Resident Commensals

Shruti Naik et al.

SCIENCE (2012)

Review Gastroenterology & Hepatology

The role of gut microbiota in immune homeostasis and autoimmunity

Hsin-Jung Wu et al.

GUT MICROBES (2012)

Article Public, Environmental & Occupational Health

Cutaneous Melanoma and Endogenous Hormonal Factors: A Large French Prospective Study

Marina Kvaskoff et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)

Review Food Science & Technology

Factors That Affect the Content of Heterocyclic Aromatic Amines in Foods

Maite Sanz Alaejos et al.

COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2011)

Article Medicine, General & Internal

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Multidisciplinary Sciences

Microbiota regulates immune defense against respiratory tract influenza A virus infection

Takeshi Ichinohe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Dermatology

Induction of skin carcinogenicity by alcohol and ultraviolet light

R. N. Saladi et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Cell Biology

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Peter J. Turnbaugh et al.

SCIENCE TRANSLATIONAL MEDICINE (2009)

Article Multidisciplinary Sciences

Clonal integration of a polyomavirus in human Merkel cell carcinoma

Huichen Feng et al.

SCIENCE (2008)

Review Medicine, General & Internal

A prospective study of red and processed meat intake in relation to cancer risk

Amanda J. Cross et al.

PLOS MEDICINE (2007)

Article Nutrition & Dietetics

Nutritional composition of red meat

Peter Williams

NUTRITION & DIETETICS (2007)

Article Oncology

Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women

D Feskanich et al.

BRITISH JOURNAL OF CANCER (2003)